Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 5:51 PM UTC
| NCT Number | NCT04588922 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 160 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Sellas Life Sciences Group |
| Last Updated on CT.gov | September 3, 2026 (Sep 3, 2026) |
As of October 15, 2026: Clinical trial NCT04588922 is currently recruiting participants. This phase1 study for acute myeloid leukemia is actively seeking new participants at 19 locations across the United States. The study is sponsored by Sellas Life Sciences Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04588922 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04588922 was last updated Sep 3, 2026 (September 3, 2026). HelloStudys verifies this status automatically.